Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Fulcrum Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
oct 29
Estimación de BPA
$-0.290
Estimación de ingresos trimestrales
–
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
–
Analice el historial de beneficios de Fulcrum Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
FULC | Fulcrum Therapeutics | -$0.32 | -$0.29 | — | — | $0.00 | — | — | — | 10/29/2025 | |
FULC | Fulcrum Therapeutics | $0.87 | -$0.29 | -$0.28 | 3.45% | $80.00M | — | $0.00 | — | 07/29/2025 | |
FULC | Fulcrum Therapeutics | -$0.43 | -$0.32 | -$0.28 | 12.50% | $0.00 | — | $0.00 | — | 05/01/2025 | |
FULC | Fulcrum Therapeutics | -$0.40 | -$0.29 | -$0.31 | -6.90% | $871.00K | — | $0.00 | — | 02/25/2025 | |
FULC | Fulcrum Therapeutics | -$0.39 | -$0.41 | -$0.32 | 21.95% | $759.00K | — | $0.00 | — | 11/13/2024 | |
FULC | Fulcrum Therapeutics | -$0.38 | -$0.01 | $0.87 | 8800.00% | $880.00K | $36.54M | $80.00M | 118.94% | 07/31/2024 | |
FULC | Fulcrum Therapeutics | -$0.41 | -$0.44 | -$0.43 | 2.27% | $259.00K | $360.00K | $0.00 | -100.00% | 05/13/2024 | |
FULC | Fulcrum Therapeutics | -$0.50 | -$0.43 | -$0.40 | 6.98% | $685.00K | $460.00K | $871.00K | 89.35% | 02/27/2024 | |
FULC | Fulcrum Therapeutics | -$0.51 | -$0.44 | -$0.39 | 11.36% | $1.18M | $1.05M | $759.00K | -27.71% | 11/07/2023 | |
FULC | Fulcrum Therapeutics | -$0.83 | -$0.44 | -$0.38 | 13.64% | $1.88M | $1.60M | $880.00K | -45.00% | 08/03/2023 | |
FULC | Fulcrum Therapeutics | -$0.64 | -$0.46 | -$0.41 | 10.87% | $2.59M | $1.13M | $259.00K | -77.08% | 05/15/2023 | |
FULC | Fulcrum Therapeutics | -$0.58 | -$0.49 | -$0.50 | -2.04% | $5.06M | $1.65M | $685.00K | -58.48% | 03/09/2023 | |
FULC | Fulcrum Therapeutics | -$0.57 | -$0.62 | -$0.51 | 17.74% | $4.93M | $2.54M | $1.18M | -53.43% | 11/08/2022 | |
FULC | Fulcrum Therapeutics | -$0.60 | -$0.66 | -$0.83 | -25.76% | $4.38M | $2.96M | $1.88M | -36.42% | 08/11/2022 | |
FULC | Fulcrum Therapeutics | -$0.54 | -$0.63 | -$0.64 | -1.59% | $4.79M | $3.94M | $2.59M | -34.21% | 05/09/2022 | |
FULC | Fulcrum Therapeutics | -$0.64 | -$0.73 | -$0.58 | 20.55% | $4.22M | $2.68M | $5.06M | 88.73% | 03/03/2022 | |
FULC | Fulcrum Therapeutics | -$0.70 | -$0.65 | -$0.57 | 12.31% | $1.85M | $2.25M | $4.93M | 119.33% | 11/04/2021 | |
FULC | Fulcrum Therapeutics | -$0.66 | -$0.62 | -$0.60 | 3.23% | $2.00M | — | $4.38M | — | 08/10/2021 | |
FULC | Fulcrum Therapeutics | -$0.81 | -$0.66 | -$0.54 | 18.18% | $750.00K | $1.42M | $4.79M | 237.25% | 05/06/2021 | |
FULC | Fulcrum Therapeutics | -$0.71 | — | -$0.64 | — | $0.00 | $1.31M | $4.22M | 222.52% | 03/04/2021 | |
FULC | Fulcrum Therapeutics | -$0.97 | -$0.65 | -$0.70 | -7.69% | $0.00 | $550.00K | $1.85M | 236.00% | 11/10/2020 |
Fulcrum Therapeutics (FULC) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-29 | $-0.28 | $-0.29 | 3.45 % |
| Q1 | 2025-05-01 | $-0.28 | $-0.32 | 12.5 % |
| Q4 | 2025-02-25 | $-0.31 | $-0.29 | -6.90 % |
| Q3 | 2024-11-13 | $-0.32 | $-0.41 | 21.9 % |
Fulcrum Therapeutics (FULC) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2024-07-31 | $80.00M | $36.54M | 118.9 % |
| Q1 | 2024-05-13 | $0 | $360.00K | -100.0 % |
| Q4 | 2024-02-27 | $871.00K | $460.00K | 89.3 % |
| Q3 | 2023-11-07 | $759.00K | $1.05M | -27.7 % |
PREGUNTAS FRECUENTES
¿Cuándo Fulcrum Therapeutics (NASDAQ:FULC) publicará los resultados?
Está previsto que Fulcrum Therapeutics (FULC) presente resultados el octubre 29, 2025. Los últimos resultados se publicaron el julio 29, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Fulcrum Therapeutics (NASDAQ:FULC)?
El BPA real fue de $-0.28, que superó la estimación de $-0.29.
¿Cuáles fueron los ingresos de Fulcrum Therapeutics (NASDAQ:FULC)?
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.